NCAA Tournament hopes are done and gone after a 76-56 loss to Iowa State in the second round of the Big 12 tournament.

Presented a poster highlighting the use of the Company's Magellan™ drug discovery platform to identify allosteric inhibitors ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...